Skip to main content
SpringerLink
Log in

Lack of evidence for allopurinol for the prevention of a first gout attack in asymptomatic hyperuricemia: a systematic review

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Bursill D, Taylor WJ, Terkeltaub R, Kuwabara M, Merriman TR, Grainger R, Pineda C, Louthrenoo W, Edwards NL, Andrés M, Vargas-Santos AB, Roddy E, Pascart T, Lin CT, Perez-Ruiz F, Tedeschi SK, Kim SC, Harrold LR, McCarthy G, Kumar N, Chapman PT, Tausche AK, Vazquez-Mellado J, Gutierrez M, da Rocha Castelar-Pinheiro G, Richette P, Pascual E, Fisher MC, Burgos-Vargas R, Robinson PC, Singh JA, Jansen TL, Saag KG, Slot O, Uhlig T, Solomon DH, Keenan RT, Scire CA, Biernat-Kaluza E, Dehlin M, Nuki G, Schlesinger N, Janssen M, Stamp LK, Sivera F, Reginato AM, Jacobsson L, Lioté F, Ea HK, Rosenthal A, Bardin T, Choi HK, Hershfield MS, Czegley C, Choi SJ, Dalbeth N (2019) Gout, hyperuricemia, and crystal-associated disease network consensus statement regarding labels and definitions for disease elements in gout. Arthritis Care Res 71(3):427–434

    Article  Google Scholar 

  2. Bardin T, Richette P (2014) Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol 26(2):186–191

    Article  CAS  Google Scholar 

  3. Yip K, Cohen RE, Pillinger MH (2020 Jan) Asymptomatic hyperuricemia: is it really asymptomatic? Curr Opin Rheumatol 32(1):71–79

    Article  CAS  Google Scholar 

  4. Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK (2019) Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007-2016. Arthritis Rheumatol 71(6):991–999

    Article  Google Scholar 

  5. Stamp L, Dalbeth N (2017) Urate-lowering therapy for asymptomatic hyperuricaemia: a need for caution. Semin Arthritis Rheum 46(4):457–464

    Article  Google Scholar 

  6. Dalbeth N, Phipps-Green A, Frampton C, Neogi T, Taylor WJ, Merriman TR (2018) Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis. Ann Rheum Dis 77(7):1048–1052

    Article  CAS  Google Scholar 

  7. Bardin T, Bouée S, Clerson P, Chalès G, Flipo R-M, Lioté F et al (2016) Prevalence of gout in the adult population of France. Arthritis Care Res 68(2):261–266

    Article  Google Scholar 

  8. Population totale par sexe et âge au 1er janvier 2019, France − Bilan démographique 2018 | Insee [Internet]. [cited 2019 Dec 9]. Available from: https://www.insee.fr/fr/statistiques/1892086?sommaire=1912926

  9. Haute Autorité de Santé - ZYLORIC [Internet]. [cited 2020 Feb 3]. Available from: https://www.has-sante.fr/portail/jcms/c_2655929/fr/zyloric

  10. Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castañeda-Sanabria J et al (2017 Jan) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76(1):29–42

    Article  CAS  Google Scholar 

  11. Assurance Maladie. Données mensuelles et annuelles sur les médicaments remboursés par l’Assurance Maladie [Internet]. Medic’AM. 2018. Available from: https://www.ameli.fr/l-assurance-maladie/statistiques-et-publications/donnees-statistiques/medicament/medic-am/medic-am-mensuel-2016.php

  12. Hazard A, Pino C, Pelletier-Fleury N, Hanslik T, Saint-Lary O, Blanchon T et al (2017 Jun) «Top five list» française en médecine générale - Protocole de l’étude. Exercer. 134:282–286

    Google Scholar 

  13. Tourzel E, Munck S, Fournier J-P, Maisonneuve H (2019 Sep) Factors influencing urate lowering therapies prescription for asymptomatic hyperuricemia by general practitioners: a qualitative study. Int J Clin Pract 73(9):1–11

    Article  Google Scholar 

  14. Vinik O, Wechalekar MD, Falzon L, Buchbinder R, van der Heijde DM, Bombardier C (2014 Sep) Treatment of asymptomatic hyperuricemia for the prevention of gouty arthritis, renal disease, and cardiovascular events: a systematic literature review. J Rheumatol Suppl 92:70–74

    Article  Google Scholar 

  15. Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions: Cochrane Book Series 2008;674

  16. Li Q, Li X, Wang J, Liu H, Kwong JS-W, Chen H et al (2019) Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements. BMJ Open 9(8):e026677

    Article  Google Scholar 

  17. Fleeman N, Pilkington G, Dundar Y, Dwan K, Boland A, Dickson R et al (2014) Allopurinol for the treatment of chronic kidney disease: a systematic review. Health Technol Assess 18(40):1–vi

    Article  Google Scholar 

  18. Tang O, Miller ER, Gelber AC, Choi HK, Appel LJ, Juraschek SP (2017) DASH diet and change in serum uric acid over time. Clin Rheumatol 36(6):1413–1417

    Article  Google Scholar 

  19. Rai SK, Fung TT, Lu N, Keller SF, Curhan GC, Choi HK (2017) The dietary approaches to stop hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study. BMJ. 9:j1794

    Article  Google Scholar 

  20. Kawamoto R, Katoh T, Ninomiya D, Kumagi T, Abe M, Kohara K (2016) Synergistic association of changes in serum uric acid and triglycerides with changes in insulin resistance after walking exercise in community-dwelling older women. Endocr Res 41(2):116–123

    Article  CAS  Google Scholar 

  21. Nielsen SM, Bartels EM, Henriksen M, Wæhrens EE, Gudbergsen H, Bliddal H et al (2017) Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies. Ann Rheum Dis 76(11):1870–1882

    Article  Google Scholar 

  22. Chalès G (2019) How should we manage asymptomatic hyperuricemia? Joint Bone Spine 86(4):437–443

    Article  Google Scholar 

Download references

Acknowledgements

Thanks are due to the following: Jinane El Jabry, Carla Coelho, Jocelyn Larue; Les Médecins du Réseau sentinelles.

Funding

L’Institut Pierre-Louis d’épidémiologie et de santé publique (IPLESP), le Centre de recherche en Épidémiologie et Santé des Populations (CESP), and l’Université de Versailles-Saint-Quentin-en-Yvelines are project owners. Centre de recherche en Epidémiologie et Santé de Populations (CESP) and the Caisse Nationale d’Assurance Maladie (CNAM) are project funders.

Author information

Authors and Affiliations

  1. Département de médecine générale, UFR des sciences de la santé Simone Veil, Université Versailles-Saint-Quentin-en-Yvelines, Montigny le Bretonneux, France

    A. Hazard, B. Bourrion, F. Dechaine & M. François

  2. INSERM, Centre de Recherche en Epidémiologie et Santé des Populations, UMR1018, Hôpital Paul Brousse, Université Paris Saclay, bat 15-16, 16 avenue Paul Vaillant Couturier, 94807, Villejuif CEDEX, France

    B. Bourrion & M. François

  3. INSERM, Institut Pierre Louis d’épidémiologie et de Santé Publique (IPLESP UMRS 1136), Sorbonne Université, F-75012, Paris, France

    L. Fournier

Authors
  1. A. Hazard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Bourrion
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Dechaine
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Fournier
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. François
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Bastien Bourrion, Florian Dechaine, Lucie Fournier, and Agnès Hazard. The first draft of the manuscript was written by Agnès Hazard and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript. This work was supervised by Mathilde François.

Corresponding author

Correspondence to A. Hazard.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hazard, A., Bourrion, B., Dechaine, F. et al. Lack of evidence for allopurinol for the prevention of a first gout attack in asymptomatic hyperuricemia: a systematic review. Eur J Clin Pharmacol 76, 897–899 (2020). https://doi.org/10.1007/s00228-020-02849-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-020-02849-5

Search

Navigation